Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
First Treatment Period	STARTED	Methoxy Polyethylene Glycol-Epoetin Beta	748
First Treatment Period	STARTED	Comparator ESA	480
First Treatment Period	COMPLETED	Methoxy Polyethylene Glycol-Epoetin Beta	492
First Treatment Period	COMPLETED	Comparator ESA	302
First Treatment Period	NOT COMPLETED	Methoxy Polyethylene Glycol-Epoetin Beta	256
First Treatment Period	NOT COMPLETED	Comparator ESA	178
Extended Treatment Period	STARTED	Methoxy Polyethylene Glycol-Epoetin Beta	453
Extended Treatment Period	STARTED	Comparator ESA	250
Extended Treatment Period	COMPLETED	Methoxy Polyethylene Glycol-Epoetin Beta	94
Extended Treatment Period	COMPLETED	Comparator ESA	59
Extended Treatment Period	NOT COMPLETED	Methoxy Polyethylene Glycol-Epoetin Beta	359
Extended Treatment Period	NOT COMPLETED	Comparator ESA	191

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00090753/flow